PHMEDIUM SIGNALFINANCIAL10-K

Parker Hannifin delivered strong financial performance with meaningful growth in net income and revenue, while strengthening its balance sheet through debt reduction.

The company demonstrated solid execution with net income growing substantially and revenue expanding nearly 19%, indicating strong demand across its diversified industrial and aerospace segments. The balance sheet improvements, including reduced debt levels and lower current liabilities, position the company well for continued operations and potential growth investments.

Comparing 2025-08-22 vs 2024-08-22View on EDGAR →
FINANCIAL ANALYSIS

Parker Hannifin showed robust financial performance with revenue growing to $14.3 billion and net income reaching $2.8 billion, representing meaningful expansion in profitability. The company strengthened its financial position by reducing total debt to $7.5 billion and cutting current liabilities by over 20%, while maintaining healthy operating cash flow growth of nearly 12%. The combination of strong earnings growth and improved balance sheet metrics signals effective operational execution and disciplined capital management.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+36.5%
$2.1B→$2.8B

Net income grew 36.5% — bottom-line growth signals improving overall business health.

Current Liabilities
Balance Sheet
-20.4%
$7.3B→$5.8B

Current liabilities reduced — improved short-term financial position and working capital health.

Revenue
P&L
+18.9%
$12.0B→$14.3B

Revenue growing 18.9% — solid top-line momentum, watch margins for quality of growth.

Stockholders Equity
Balance Sheet
+13.3%
$12.1B→$13.7B

Equity base grew 13.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Gross Profit
P&L
+11.9%
$2.5B→$2.8B

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Operating Cash Flow
Cash Flow
+11.6%
$3.4B→$3.8B

Operating cash flow grew 11.6% — strong conversion of earnings to cash, healthy business fundamentals.

Total Debt
Balance Sheet
-10.8%
$8.4B→$7.5B

Debt reduced 10.8% — deleveraging strengthens balance sheet and reduces financial risk.

Cash & Equivalents
Balance Sheet
+10.7%
$422.0M→$467.0M

Cash grew 10.7% — improving liquidity position supports investment and shareholder returns.

Dividends Paid
Cash Flow
+10.1%
$782.0M→$861.0M

Dividend payments increased 10.1% — management confidence in sustained cash generation.

LANGUAGE CHANGES
NEW — 2025-08-22
PRIOR — 2024-08-22
ADDED
The number of Common Shares outstanding on July 31, 2025 was 126,682,154 .
Of the Company's $19.9 billion in net sales for fiscal year 2025, Diversified Industrial Segment products accounted for 69 percent and Aerospace Systems Segment products accounted for 31 percent.
Our backlog was $11.0 billion at June 30, 2025 and $10.9 billion at June 30, 2024.
Approximately 71 percent of our backlog at June 30, 2025 is scheduled for delivery in the succeeding twelve months.
On June 30, 2025, the Company announced that it has agreed to acquire Curtis Instruments, Inc.
+7 more — sign up free →
REMOVED
The number of Common Shares outstanding on July 31, 2024 was 128,595,729 .
Of the Company's $19.9 billion in net sales for fiscal year 2024, Diversified Industrial Segment products accounted for 73 percent and Aerospace Systems Segment products accounted for 27 percent.
Our backlog was $10.9 billion at June 30, 2024 and $11.0 billion at June 30, 2023.
Approximately 73 percent of our backlog at June 30, 2024 is scheduled for delivery in the succeeding twelve months.
The Acquisition is discussed in Note 3 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K and is incorporated herein by reference.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →